Home Cart 0 Sign in  
X

[ CAS No. 1899-24-7 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1899-24-7
Chemical Structure| 1899-24-7
Chemical Structure| 1899-24-7
Structure of 1899-24-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 1899-24-7 ]

Related Doc. of [ 1899-24-7 ]

Alternatived Products of [ 1899-24-7 ]

Product Details of [ 1899-24-7 ]

CAS No. :1899-24-7 MDL No. :MFCD00159501
Formula : C5H3BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :WJTFHWXMITZNHS-UHFFFAOYSA-N
M.W :174.98 Pubchem ID :600328
Synonyms :

Calculated chemistry of [ 1899-24-7 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.8
TPSA : 30.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.26
Log Po/w (XLOGP3) : 1.81
Log Po/w (WLOGP) : 1.85
Log Po/w (MLOGP) : 0.27
Log Po/w (SILICOS-IT) : 2.13
Consensus Log Po/w : 1.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.46
Solubility : 0.604 mg/ml ; 0.00345 mol/l
Class : Soluble
Log S (Ali) : -2.06
Solubility : 1.51 mg/ml ; 0.00863 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.41
Solubility : 0.684 mg/ml ; 0.00391 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.01

Safety of [ 1899-24-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1899-24-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1899-24-7 ]
  • Downstream synthetic route of [ 1899-24-7 ]

[ 1899-24-7 ] Synthesis Path-Upstream   1~36

  • 1
  • [ 179055-22-2 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 13, p. 2390 - 2410
  • 2
  • [ 4915-06-4 ]
  • [ 1899-24-7 ]
Reference: [1] Patent: US4332952, 1982, A,
  • 3
  • [ 35950-55-1 ]
  • [ 1899-24-7 ]
  • [ 563-70-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 3, p. 795 - 804
  • 4
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
Reference: [1] Tetrahedron, 1996, vol. 52, # 36, p. 11763 - 11782
[2] Zhurnal Obshchei Khimii, 1954, vol. 24, p. 575,576; engl. Ausg. S. 589, 590[3] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 2012; engl. Ausg. S. 2070
[4] Collection of Czechoslovak Chemical Communications, 1996, vol. 61, # 8, p. 1233 - 1243
  • 5
  • [ 35950-55-1 ]
  • [ 1899-24-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 3, p. 795 - 804
  • 6
  • [ 585-70-6 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 13, p. 2390 - 2410
  • 7
  • [ 1137088-24-4 ]
  • [ 1899-24-7 ]
Reference: [1] Australian Journal of Chemistry, 2010, vol. 63, # 12, p. 1619 - 1626
  • 8
  • [ 613-75-2 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of the American Chemical Society, 1930, vol. 52, p. 1170
  • 9
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
  • [ 2433-85-4 ]
  • [ 21921-76-6 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
[2] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
[3] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
  • 10
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
  • [ 2433-85-4 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
  • 11
  • [ 89167-32-8 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1941, vol. 6, p. 157,165
  • 12
  • [ 854819-96-8 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1941, vol. 6, p. 157,165
  • 13
  • [ 854753-06-3 ]
  • [ 1899-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1941, vol. 6, p. 157,165
  • 14
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
  • [ 21921-76-6 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
  • 15
  • [ 613-75-2 ]
  • [ 7726-95-6 ]
  • [ 1899-24-7 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1933, vol. <2> 136, p. 232,233
[2] Journal of the American Chemical Society, 1930, vol. 52, p. 1170
  • 16
  • [ 186581-53-3 ]
  • [ 1899-24-7 ]
  • [ 3199-50-6 ]
Reference: [1] Journal of the American Chemical Society, 1931, vol. 53, p. 4192,4196
[2] Indian Journal of Chemistry - Section B Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 11, p. 993 - 995
  • 17
  • [ 1899-24-7 ]
  • [ 27230-58-6 ]
  • [ 585-70-6 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1990, vol. 26, # 6, p. 617 - 620[2] Khimiya Geterotsiklicheskikh Soedinenii, 1990, # 6, p. 741 - 744
  • 18
  • [ 1899-24-7 ]
  • [ 585-70-6 ]
Reference: [1] Vestnik Moskovskogo Universiteta, 1958, vol. 13, # 5, p. 119,121[2] Chem.Abstr., 1959, p. 12267
[3] Journal of Physical Organic Chemistry, 2004, vol. 17, # 1, p. 83 - 87
  • 19
  • [ 1899-24-7 ]
  • [ 2527-99-3 ]
Reference: [1] Vestnik Moskovskogo Universiteta, 1958, vol. 13, # 5, p. 119,121[2] Chem.Abstr., 1959, p. 12267
  • 20
  • [ 1899-24-7 ]
  • [ 52938-97-3 ]
Reference: [1] Heterocycles, 2014, vol. 89, # 2, p. 453 - 464
  • 21
  • [ 1899-24-7 ]
  • [ 34035-03-5 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 19, p. 2657 - 2659
  • 22
  • [ 1899-24-7 ]
  • [ 5575-51-9 ]
  • [ 34035-03-5 ]
Reference: [1] Synlett, 2012, vol. 23, # 13, p. 1907 - 1912
  • 23
  • [ 1899-24-7 ]
  • [ 1679-18-1 ]
  • [ 34035-03-5 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 8, p. 2273 - 2277
[2] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 19, p. 2681 - 2683
[3] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2481 - 2486
  • 24
  • [ 1899-24-7 ]
  • [ 34035-03-5 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
  • 25
  • [ 1899-24-7 ]
  • [ 24067-17-2 ]
  • [ 7147-77-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 19, p. 2681 - 2683
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2481 - 2486
[3] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 11, p. 2621 - 2626
  • 26
  • [ 1899-24-7 ]
  • [ 7147-77-5 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
  • 27
  • [ 1899-24-7 ]
  • [ 5467-74-3 ]
  • [ 20005-42-9 ]
YieldReaction ConditionsOperation in experiment
7% With tetrabutylammomium bromide; palladium diacetate; potassium carbonate In water at 20℃; for 5 h; To a glass flask, 3 (113.8 mg, 0.650mmol), (4-bromophenyl)boronic acid (143.6 mg, 0.715 mmol), tetrabutylammonium bromide(209.6 mg, 0.650 mmol), Pd(OAc)2 (2.9 mg, 0.013 mmol) and K2CO3 (224.6 mg, 1.63 mmol)were added and then dissolved in deionized water (3 mL). The reaction mixture was stirred vigorously for 5 h at room temperature. After the white reaction mixture had become yellowand non-homogeneous, the mixture was diluted with water (10 mL), and the product was extracted with EtOAc. The organics were separated, filtered through a Celite pad, and dried with MgSO4. The organic solvent was removed under reduced pressure and the crude product was purified by dry-flash chromatography (SiO2: hexane/EtOAc = 9/1 to 7/3) to afford the title compound 5 (11 mg, 7 percent).
Reference: [1] Organic Letters, 2018, vol. 20, # 8, p. 2273 - 2277
[2] Organic Letters, 1999, vol. 1, # 7, p. 965 - 967
[3] Journal of the Serbian Chemical Society, 2017, vol. 82, # 6, p. 641 - 649
[4] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 19, p. 2681 - 2683
  • 28
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
  • [ 2433-85-4 ]
  • [ 21921-76-6 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
[2] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
[3] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
  • 29
  • [ 98-01-1 ]
  • [ 1899-24-7 ]
  • [ 21921-76-6 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 927 - 928
  • 30
  • [ 1899-24-7 ]
  • [ 4915-06-4 ]
YieldReaction ConditionsOperation in experiment
85% With tert.-butylhydroperoxide; ammonium acetate; iodine; sodium carbonate In ethanol at 50℃; for 4.5 h; In a 25 mL two-necked round bottom flask equipped with a thermometer and a magnetic stirrer4mmol5-bromofuran-2-carbaldehyde (1-18), 6 mmol of NH4OAc, 4 mmol of Na2CO3, 4.4 mmol of TBHP, 0.1 mmol of I2, 5 mL of absolute ethanol Solvent, and then the reaction flask was placed in an oil bath preheated to 50 ° C and opened with a magnetic stirrer for 4.5 h. reaction The solution was stirred by adding sodium thiosulfate solution and then extracted with ether. The organic layer was separated and the solvent was evaporated under reduced pressure. The elution was carried out with a mixture of ethyl acetate / petroleum ether in a volume ratio of 1: 100 as an eluent, and the eluate containing the target compound was collected And the solvent was evaporated to give 5-bromofuran-2-carbonitrile with an isolated yield of 85percent.
82% With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium perchlorate; acetic acid; lithium hexamethyldisilazane In acetonitrile for 15 h; Electrochemical reaction General procedure: Preparative electrolysis experiments were performed using 263 APotentiostat/Galvanostat (Princeton Applied Research, USA). 0.1 MNaClO4–CH3CN solution (10 mL) containing aldehydes (1 mmol),TEMPO (0.1 mmol), HMDS (2.5mmol) and AcOH (2.5mmol) was electrolyzedwith stirring in an undivided cell (30 mL) equipped with twoplatinum sheets as anode (1.5 cm2) and cathode (3.0 cm2) respectivelyat a constant potential of 1.5 V vs Ag/Ag+ (0.1MAgNO3 in acetonitrile).The electrode separation was 1 cm. When the reaction was finished,10mL of saturatedNa2SO3 solution was added into the reactionmixtureand stirred for 15 min. Then the mixture was extracted with CH2Cl2(20 mL × 3). The organic layer was dried with anhydrous Na2SO4 andconcentrated in a rotary evaporator. The productswere obtained via purificationof column chromatography and their structures were confirmedby 1H NMR, 13C NMR and MS. NMR was performed on a BrukerAvance III spectrometer. GC-MS was performed on the Thermo TraceISQ instrument with TG 5MS capillary column.
Reference: [1] Chemistry of Heterocyclic Compounds, 2002, vol. 38, # 5, p. 524 - 529
[2] Advanced Synthesis and Catalysis, 2016, vol. 358, # 7, p. 1157 - 1163
[3] RSC Advances, 2017, vol. 7, # 3, p. 1484 - 1489
[4] Electrochimica Acta, 2017, vol. 226, p. 53 - 59
[5] Patent: CN106748881, 2017, A, . Location in patent: Paragraph 0050
[6] Electrochemistry Communications, 2016, vol. 64, p. 51 - 55
[7] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1986, vol. 22, # 2, p. 140 - 145[8] Khimiya Geterotsiklicheskikh Soedinenii, 1986, vol. 22, # 2, p. 181 - 186
[9] Patent: EP1792613, 2007, A2, . Location in patent: Page/Page column 46
[10] Angewandte Chemie - International Edition, 2015, vol. 54, # 14, p. 4241 - 4245
  • 31
  • [ 1899-24-7 ]
  • [ 67-56-1 ]
  • [ 4915-06-4 ]
Reference: [1] Catalysis Science and Technology, 2016, vol. 6, # 20, p. 7429 - 7436
  • 32
  • [ 1899-24-7 ]
  • [ 99768-12-4 ]
  • [ 53355-29-6 ]
YieldReaction ConditionsOperation in experiment
81% With potassium fluoride; tri-tert-butyl phosphine In 1,4-dioxane; hexane at 65 - 70℃; for 4 h; A solution of 5-bromofuraldehyde (2.43 g, 13.9 mmoles), 4-(methoxycarbonyl)phenylboronic acid (2.50 g, 13.9 mmoles), tris(dibenzylideneacetone)palladium (0) (192 mg, 0.2 mmoles) and potassium fluoride (2.42 g, 41.7 mmoles) in 1,4-dioxane (100 ml) was added with a solution of tri-toert-butylphosphine in hexane (10percent by weight, 101 mg, 0.5 mmoles). After heating at 65-70°C for 4 hours, the mixture was cooled to room temperature and treated with methylene chloride (150 ml). After stirring for 10 minutes, the mixture was filtered through Celite and the filtrate was EPO <DP n="13"/>concentrated under reduced pressure. The residue was purified by flash silica gel chromatography eluting with an ethyl acetate-hexane mixture (1 : 1) to give 4-(5-formyl-furan-2-yl)-benzoic acid methyl ester (2.6 g, 81percent yield).1H NMR (300 MHz, CDCl3): δ 9.70 (s, IH), 8.10 (d, 2H), 7.90 (d, 2H), 7.35 (d, IH), 6.95 (d, IH), 3.98 (s, 3H).
78% With palladium diacetate; sodium carbonate In water; acetone at 20℃; for 0.416667 h; To a solution of sodium carbonate (588.2 mg, 5.55 mmol) in H2O /acetone (278 mL/ 555 mL) was added 5-bromo-2-furaldehyde (1.9 g, 11 mmol), p-(methoxycarbonyl)phenyl boronic acid (2.0 g, 11 mmol) followed by palladium acetate(24.9 mg, 0.111 mmol) in acetone (278 ml). The reaction mixture was stirred at room temperature for 25 min. The reactionwas quenched by diluting with EtOAc (855 mL) and the organic layer was washed with 1 M HCl (500 mL) twice andwith brine (500 mL) once. The organic layer was dried over Na2SO4 and filtered with silica gel, which was concentratedin vacuo. The residue was purified by flash column chromatography (CH2Cl2/hexane = 9/ 1) to give compound 9 as whitesolid (2.0 g, 8.7 mmol, 78percent)
73% With Pd(N,N-dimethyl-β-alaninate)2; sodium carbonate In ethanol; water at 120℃; for 0.166667 h; Microwave irradiation; Sealed tube General procedure: To a solution of the appropriate bromo-substituted heterocyclic aldehydes 17a (1.0 mmol) in EtOH/H2O 5:3 (tot 12 mL) in a 35 mL CEM microwave vessel, the correspondent boronic acids 18c-d (1.2 mmol), Na2CO3 2M (2.0 mmol) and Pd(N,N-Dimethyl β-alaninate)2 (5 molpercent) were added. The vessel was capped and placed in a microwave reactor and the reaction carried out with the following method in dynamic mode: 120° C, 10 min, 50W, with high stirring. After completion the vessel was allowed to cool to room temperature and the mixture was extracted with EtOAc (3 X 10 mL). The organic phase was collected, dried over anhydrous Na2SO4, and the solvent evaporated under vacuum. The crude product (containing a small portion of the ethyl ester as a transesterification product) was then purified via silica gel column chromatography (petroleum ether/EtOAc elution gradient from a 90/10 ratio to a 80/20 ratio) to obtain the pure compounds (yield 40-60percent) (Scheme 1).
Reference: [1] Patent: WO2006/66846, 2006, A1, . Location in patent: Page/Page column 11; 12
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 9, p. 1562 - 1565
[3] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 63 - 70
  • 33
  • [ 1899-24-7 ]
  • [ 619-44-3 ]
  • [ 53355-29-6 ]
YieldReaction ConditionsOperation in experiment
78% With potassium phosphate In N,N-dimethyl acetamide at 60℃; for 24 h; Irradiation; Green chemistry General procedure: To a solution of 1 (0.3 mmol) and 2 (0.45mmol) in DMA (5 mL) was added 3wtpercent Pd/CeO2 (80 mg). The reaction mixture was stirred under incandescent light (0.79 Wcm-2) irradiation at 60°C for 24h. After reaction (monitored by TLC), when the reaction is complete, in test tube extraction and centrifugal separation allows for isolation of the desired product, while the catalyst can be washed with ethanol and water, dried under vacuum, and reused for the next run. After completion of the reaction (monitored by TLC), water (5 mL) was added and the mixture was extracted with EtOAc (3 × 5 mL). The combined organic phase was dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was purified by chromatography on silica gel (10:1 petroleum ether/EtOAc) to give the target product.
Reference: [1] Chinese Chemical Letters, 2018, vol. 29, # 6, p. 903 - 906
  • 34
  • [ 1899-24-7 ]
  • [ 13716-12-6 ]
  • [ 99768-12-4 ]
  • [ 53355-29-6 ]
YieldReaction ConditionsOperation in experiment
81% With potassium fluoride In hexane; dichloromethane A.
4-(5-Formyl-furan-2-yl)-benzoic Acid Methyl Ester
To a solution of 5-bromofuraldehyde (2.43 g, 13.9 mmol), 4-(methoxycarbonyl)phenyl boronic acid (2.50 g, 13.9 mmol), tris(dibenzylideneacetone)dipalladium(0) (192 mg, 0.21 mmol) and potassium fluoride (2.42 g, 41.7 mmol) in 1,4-doxane (100 ml) was added a solution of tri-t-butylphosphine in hexane (10 weight percent, 1.01 g, 0.5 mmol).
After heating at 65-70° C. for 4 hours, the mixture was cooled to room temperature and treated with dichloromethane (150 ml).
After stirring for 10 minutes, the mixture was filtered through a pad of celite and the filtrate was concentrated under reduced pressure.
The residue was purified by flash chromatography on silica gel eluding with ethyl acetate-hexane (1:1) to provide 4-(5-formyl-furan-2-yl)-benzoic acid methyl ester (2.6 g, 81percent yield).
Reference: [1] Patent: US2004/2526, 2004, A1,
  • 35
  • [ 1899-24-7 ]
  • [ 53355-29-6 ]
Reference: [1] Patent: CN106565643, 2017, A,
  • 36
  • [ 1899-24-7 ]
  • [ 5419-55-6 ]
  • [ 27329-70-0 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1899-24-7 ]

Bromides

Chemical Structure| 585-70-6

[ 585-70-6 ]

5-Bromofuran-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 3199-50-6

[ 3199-50-6 ]

1-(5-Bromofuran-2-yl)ethanone

Similarity: 0.83

Chemical Structure| 123837-09-2

[ 123837-09-2 ]

2-Bromo-5-methylfuran

Similarity: 0.82

Chemical Structure| 2527-99-3

[ 2527-99-3 ]

Methyl 5-bromofuran-2-carboxylate

Similarity: 0.78

Chemical Structure| 6132-37-2

[ 6132-37-2 ]

Ethyl 5-bromofuran-2-carboxylate

Similarity: 0.75

Aldehydes

Chemical Structure| 823-82-5

[ 823-82-5 ]

Furan-2,5-dicarbaldehyde

Similarity: 0.72

Chemical Structure| 21921-76-6

[ 21921-76-6 ]

4-Bromofuran-2-carbaldehyde

Similarity: 0.67

Chemical Structure| 32487-58-4

[ 32487-58-4 ]

3-Methoxyfuran-2-carbaldehyde

Similarity: 0.64

Chemical Structure| 623-30-3

[ 623-30-3 ]

3-(Furan-2-yl)acrylaldehyde

Similarity: 0.63

Chemical Structure| 39511-08-5

[ 39511-08-5 ]

(E)-3-(Furan-2-yl)acrylaldehyde

Similarity: 0.63

Related Parent Nucleus of
[ 1899-24-7 ]

Furans

Chemical Structure| 585-70-6

[ 585-70-6 ]

5-Bromofuran-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 3199-50-6

[ 3199-50-6 ]

1-(5-Bromofuran-2-yl)ethanone

Similarity: 0.83

Chemical Structure| 123837-09-2

[ 123837-09-2 ]

2-Bromo-5-methylfuran

Similarity: 0.82

Chemical Structure| 2527-99-3

[ 2527-99-3 ]

Methyl 5-bromofuran-2-carboxylate

Similarity: 0.78

Chemical Structure| 6132-37-2

[ 6132-37-2 ]

Ethyl 5-bromofuran-2-carboxylate

Similarity: 0.75